Literature DB >> 11536040

Ras adenoviruses modulate cyclin E protein expression and DNA synthesis after partial hepatectomy.

T Lüdde1, S Kubicka, J Plümpe, C Liedtke, M P Manns, C Trautwein.   

Abstract

Ras-genes encode for proteins important for transmitting extracellular signals from the cytoplasm to the nucleus. In this study we investigated the impact of Ras on cell cycle progression after hepatectomy by using adenoviral vectors (adv) expressing beta-galactosidase (beta-gal), a dominant-negative (Ras N17) or a dominant-active (Ras 61L) form of H-Ras. Partial hepatectomy was performed in mice treated with the different adenoviruses and cell cycle progression was studied by analysing factors involved in cell cycle control during liver regeneration. After hepatectomy, adv Ras 61L increases DNA synthesis significantly in comparison to the other treatment groups. Higher Ras activity results in an early increase of transcriptional active E2F-3, which is associated with higher cyclin E, but almost unchanged cyclin D protein expression. However, Northern blot analysis and cyclin E promoter experiments indicate that, besides transcriptional mechanisms also post-transcriptional mechanisms are involved in regulating cyclin E protein expression after partial hepatectomy in mice treated with adv Ras 61L. Cyclin E phosphorylation studies demonstrate that adv Ras 61L results in hypophosphorylation of cyclin E compared to the control group at early time points after hepatectomy, when cyclin E protein expression strongly increases and there is only a minor effect on cyclin E mRNA levels. Our experiments indicate adv Ras 61L in vivo increases Cyclin E expression by higher transcription via E2F and a post-transcriptional mechanism. These mechanisms result in an earlier activation of an active CDK2/Cyclin E complex which, in turn, triggers DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11536040     DOI: 10.1038/sj.onc.1204690

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury.

Authors:  Tom Luedde; Ulrike Assmus; Torsten Wüstefeld; Andreas Meyer zu Vilsendorf; Tania Roskams; Mark Schmidt-Supprian; Klaus Rajewsky; David A Brenner; Michael P Manns; Manolis Pasparakis; Christian Trautwein
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

2.  The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPalpha is dispensable for C/EBPalpha-mediated growth regulation in vivo.

Authors:  Bo Torben Porse; Thomas Askov Pedersen; Marie Sigurd Hasemann; Mikkel Bruhn Schuster; Peggy Kirstetter; Tom Luedde; Inge Damgaard; Elke Kurz; Charlotte Karlskov Schjerling; Claus Nerlov
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

3.  Ras activity regulates cyclin E degradation by the Fbw7 pathway.

Authors:  Alex C Minella; Markus Welcker; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-24       Impact factor: 11.205

4.  CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.

Authors:  F Tacke; C Liedtke; S Bocklage; M P Manns; C Trautwein
Journal:  Gut       Date:  2005-05-04       Impact factor: 23.059

5.  Cell cycle events during the development of the silk glands in the mulberry silkworm Bombyx mori.

Authors:  Sangeeta Dhawan; K P Gopinathan
Journal:  Dev Genes Evol       Date:  2003-07-17       Impact factor: 0.900

6.  Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation.

Authors:  Aditi Pandya Martin; Anna Miller; Luni Emad; Mohammed Rahmani; Teneille Walker; Clint Mitchell; Michael P Hagan; Margaret A Park; Adly Yacoub; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2008-06-10       Impact factor: 4.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.